Literature DB >> 9766258

Growth hormone binding protein activity in obese children.

S Seminara1, A Filpo, F La Cauza, A Faedda, A Miola, S Pellizzone, M Casati, S Loche.   

Abstract

We evaluated growth hormone binding protein (GHBP) activity in a group of obese children (12 boys and 12 girls, age 3.1-14.7 years, BMI 21.1-33.3, 11 prepubertal and 13 early pubertal) and in 26 age-matched normal weight children (14 boys and 12 girls, age 2.1-16.0 years, BMI 14.2-21.4, 18 prepubertal and 8 early pubertal). All children were of normal stature. GHBP activity was significantly higher in the obese (39.1 +/- 1.1%) than in the control children (28.3 +/- 1.0%, p < 0.0001). Mean serum GHBP was not different between boys and girls or between prepubertal and pubertal subjects. A positive correlation was found between BMI and GHBP levels only in the normal weight children (r = 0.425, p < 0.05). Baseline insulin concentrations in the obese children were 97.6 +/- 7.9 pmol/l (normal values, 45.0 +/- 18.6 pmol/l), and the mean insulin AUC following OGTT in the obese was 811.3 +/- 160.7 pmol/l (normal values, 373.1 +/- 150.1 pmol/l). Serum GHBP activity in the obese was not correlated with baseline serum insulin concentrations or with the insulin AUC following OGTT. In conclusion, we found that obese children have elevated GHBP activity, and speculate that this phenomenon may serve to compensate for their reduced GH secretion and accelerated GH clearance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766258     DOI: 10.1007/BF03347323

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty.

Authors:  F Minuto; A Barreca; P Del Monte; P Fortini; M Resentini; F Morabito; G Giordano
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

2.  Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.

Authors:  S Loche; M Cappa; P Borrelli; A Faedda; A Crinò; S G Cella; R Corda; E E Müller; C Pintor
Journal:  Clin Endocrinol (Oxf)       Date:  1987-08       Impact factor: 3.478

3.  Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.

Authors:  S M Haffner; M P Stern; H P Hazuda; J A Pugh; J K Patterson
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

4.  Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes.

Authors:  R C Baxter; A S Brown; J R Turtle
Journal:  Horm Metab Res       Date:  1980-08       Impact factor: 2.936

5.  Binding protein for human growth hormone: effects of age and weight.

Authors:  R W Holl; R Snehotta; B Siegler; W Scherbaum; E Heinze
Journal:  Horm Res       Date:  1991

6.  Nutritional status and growth hormone-binding protein.

Authors:  M C Postel-Vinay; C Saab; M Gourmelen
Journal:  Horm Res       Date:  1995

7.  Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty.

Authors:  G Massa; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

8.  The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.

Authors:  S Loche; P Cambiaso; D Carta; S Setzu; B P Imbimbo; P Borrelli; C Pintor; M Cappa
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

9.  Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight.

Authors:  A Silbergeld; L Lazar; B Erster; R Keret; R Tepper; Z Laron
Journal:  Clin Endocrinol (Oxf)       Date:  1989-09       Impact factor: 3.478

10.  The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa.

Authors:  Z Hochberg; P Hertz; V Colin; S Ish-Shalom; D Yeshurun; M B Youdim; T Amit
Journal:  Metabolism       Date:  1992-01       Impact factor: 8.694

View more
  1 in total

Review 1.  Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Authors:  Xuehong Dong; Lei Su; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2022-08-24       Impact factor: 5.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.